1. Home
  2. Protocols and Guidelines
  3. Cancer Protocol Templates

Cancer Protocol Templates

The CAP Cancer Reporting Protocols provide guidelines for collecting the essential data elements for complete reporting of malignant tumors and optimal patient care.

The CAP Biomarker Reporting Protocols are intended to provide reporting guidance for commonly ordered biomarkers and are not required for accreditation purposes.

Latest News and Resources

  • Open all Toggle
  • Close all Toggle

On June 22, 2022, the College of American Pathologists released updates to 12 CAP Cancer Protocols. All changes are outlined in the Summary of Revisions with updates now available on www.cap.org.

New Cancer Reporting Protocol:

  • Protocol for Cutaneous Squamous Cell Carcinoma of the Head and Neck

Changes affecting accreditation date:

  • Anus and Appendix templates were updated to include AJCC 9th version content
  • Added answers under Histologic Type to include Squamous Cell Carcinoma grading in the Major Salivary Gland template
  • Deleted Tumor Modifier question and combined answer list with TNM Descriptors question for the Endometrium template
  • Deprecated Hepatoblastoma from the Histologic Type answers in the Hepatocellular Carcinoma template
  • Changed Distance from Invasive Carcinoma to Closest Margin from optional to core in the Lung template
  • Updated the pN3a staging classification in the Breast Invasive template

Other key content changes include:

  • Updated pN0 staging classification in the Breast Phyllodes template
  • Changed the HER2 ISH question to conditional from optional, changed the Ki-67 question to core from optional, and deprecated the Multiparametric Gene Expression question in the Breast Biomarker template

All changes are outlined in the Summary of Revisions [under Resources]

Current and previous cancer reporting and biomarker reporting protocols can be downloaded using the links in the table below.

The College of American Pathologists March 2022 release updated 19 CAP Cancer Protocols.

Highlights of these content changes include:

  • NEW Protocol – Phyllodes Tumor of the Breast
  • All Pediatric Biopsy and Resection Protocols have an added question for Expert Consultation; for Wilms Tumor resection, this change affects the accreditation date
  • Deprecated the Distance from Tumor to Vascular, Ureteral, and Soft Tissue Margin Questions for Wilms Tumor Resection: this change affects the accreditation date
  • Lymphovascular Invasion was changed from an optional to a core element in the Breast Invasive Resection template which affects the accreditation date
  • Clarified Number of Isolated Tumor Cells in the Uterine Sarcoma Resection template which affects the accreditation date
  • Other minor content changes include explanatory note updates, corrections of typographical errors, and clarification of answer choices for peritoneal ascitic fluid

All changes are outlined in the Summary of Revisions [under Resources]

The College of American Pathologists November 2021 release updated 19 CAP Cancer Protocols. Highlights of these content changes include:

  • Changed the name of the Lip and Oral Cavity to Oral Cavity to update scope of the protocol
  • Added ITC reporting question and answer set to Regional Lymph Nodes in Uterus Sarcoma – will affect accreditation date
  • Changed nested Margin questions from Conditional to Required and Remodeled Preexisting pleomorphic adenoma component question in Head and Neck Protocols
  • Updated Not Applicable statement to state "invasive melanoma" vs "invasive carcinoma" and cover page to qualify use for Invasive Melanoma Excision
  • Added a new, repeating section for other user entered biomarkers in Quantitative IHC Biomarker Reporting
  • Updated instructional and explanatory notes
  • Reformatted Questions and Answers, and reporting order of elements

There are no new or retired protocols in this release. Additionally, there were 13 protocols that underwent technical changes only to their corresponding CAP eCC template. Although these protocols did not have any content changes, they received new version numbers to reconcile our database.

All changes are outlined in the Summary of Revisions [under Resources]

Cancer Reporting and Biomarker Reporting Protocols

2013-2018 Previous Versions Are Available Upon Request

Breast

Breast DCIS, Resection

Current Version
PDF (v4.4.0.0)
Word (v4.4.0.0)
June 2021

Previous Version
2020
(v4.3.0.2)
2019 (v4.3.0.1)
2019 (v4.3.0.0)
2019 (v4.2.0.0)
Breast DCIS, Biopsy Current Version
PDF (v1.0.1.0)
Word (v1.0.1.0)
June 2021
Previous Version
2020
(v1.0.0.1)
2019 (v1.0.0.0)
Breast Phyllodes Tumor Current Version
PDF (v1.1.0.0)
Word (v1.1.0.0)
June 2022
Previous Version
2022 (v.1.0.0.0)
Breast Invasive, Resection Current Version
PDF (v4.7.0.0)
Word (v4.7.0.0)
June 2022
Previous Version
2022
 (v4.6.0.0)
2021 (v4.5.0.1)
2021 (v4.5.0.0)
2020 (v4.4.0.0)
2019 (v4.3.0.1)
Breast Invasive, Biopsy Current Version
PDF (v1.1.1.1)
Word (v1.1.1.1)
November 2021
Previous Version
2021 (v1.1.1.0)
2020
(v1.1.0.0)
2019 (v1.0.0.1)
2019 (v1.0.0.0)
Breast Biomarker Reporting Current Version
PDF (v1.5.0.0)
Word (v1.5.0.0)
June 2022
Previous Version
2021 (v1.4.1.1)
2021
(v1.4.1.0)
2020 (v1.4.0.0)
2019 (v1.3.0.0)

Central Nervous System

Central Nervous System Current Version
PDF (v4.0.0.0)
Word (v4.0.0.0)
August 2018
Previous Version
2014 (v3.1.0.2)
2014 (v3.1.0.1)

Endocrine

Adrenal Gland Current Version
PDF (v4.2.1.0)
Word (v4.2.1.0)
November 2021
Previous Version
2021
(v4.2.0.0)
2020
(v4.1.0.0)
2019 (v4.0.2.0)
Appendix NET Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2020 (v4.0.0.2)
Colon NET Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2020 (v4.0.0.2)
Duodenum and Ampulla NET Current Version
PDF (v1.1.0.0)
Word (v1.1.0.0)
June 2021
Previous Version
2020 (v1.0.0.2)
Jejunum and Ileum NET Current Version
PDF (v1.1.0.0)
Word (v1.1.0.0)
June 2021
Previous Version
2020 (v1.0.0.1)
Pancreas (Endocrine) Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2020 (v4.0.0.2)
Stomach NET Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2020 (v4.0.0.2)
Thyroid Current Version
PDF (v4.3.0.0)
Word (v4.3.0.0)
June 2021
Previous Version
2020
(v4.2.0.0)
2019 (v4.1.0.0)
Thyroid Biomarker Reporting Current Version
PDF (v1.0.0.1)
Word (v1.0.0.1)
June 2016
Previous Version
2015 (v1.0.0.0)

Gastrointestinal

Ampulla of Vater Current Version
PDF (v4.2.0.1)
Word (v4.2.0.1)
November 2021
Previous Version
2021
 (v4.2.0.0)
2020 (v4.1.0.0)
Anus, Excision Current Version
PDF (v4.2.0.0)
Word (v4.2.0.0)
June 2021
Previous Version
2020
(v4.1.0.1)
2020 (v4.1.0.0)
Anus, Resection Current Version
PDF (v5.0.0.0)
Word (v5.0.0.0)
June 2022
Previous Version
2021
 (v4.2.0.1)
2021 
(v4.2.0.0)
2020 (v4.1.0.0)
Appendix Current Version
PDF (v5.0.0.0)
Word (v5.0.0.0)
June 2022
Previous Version
2021
 (v4.2.0.0)
2020 (v4.1.0.0)
Colon and Rectum, Biopsy Current Version
PDF (v4.2.0.1)
Word (v4.2.0.1)
November 2021
Previous Version
2021 
(v4.2.0.0)
2020 (v4.1.0.0)
Colon and Rectum, Resection Current Version
PDF (v4.2.0.2)
Word (v4.2.0.2)
June 2022
Previous Version
2021
 (v4.2.0.1)
2021
 (v4.2.0.0)
2020 (v4.1.0.0)
Colon and Rectum Biomarker Reporting Current Version
PDF (v1.3.0.0)
Word (v1.3.0.0)
June 2021
Previous Version
2014 (v1.2.0.1)
Distal Extrahepatic Bile Ducts Current Version
PDF (v4.2.0.0)
Word (v4.2.0.0)
June 2021
Previous Version
2020 (v4.1.0.0)
Esophagus Current Version
PDF (v4.2.0.1)
Word (v4.2.0.1)
June 2022
Previous Version
2021
 (v4.2.0.0)
2020 (v4.1.0.0)
Gallbladder Current Version
PDF (v4.2.0.0)
Word (v4.2.0.0)
June 2021
Previous Version
2020 (v4.1.0.0)
GIST, Biopsy Current Version
PDF (v4.2.0.0)
Word (v4.2.0.0)
June 2021
Previous Version
2020 (v4.1.0.0)
GIST, Resection Current Version
PDF (v4.2.0.0)
Word (v4.2.0.0)
June 2021
Previous Version
2020 (v4.1.0.0)
GIST Biomarker Reporting Current Version
PDF (v1.0.0.2)
Word (v1.0.0.2)
February 2020
Previous Version
2015 (v1.0.0.1)
2014 (v1.0.0.0)
Hepatocellular Carcinoma Current Version
PDF (v4.3.0.0)
Word (v4.3.0.0)
June 2022
Previous Version
2021
(v4.2.0.0)
2020 (v4.1.0.0)
Intrahepatic Bile Ducts Current Version
PDF (v4.2.0.0)
Word(v4.2.0.0)
June 2021
Previous Version
2020 (v4.1.0.0)
Pancreas (Exocrine) Current Version
PDF (v4.2.0.2)
Word (v4.2.0.2)
November 2021
Previous Version
2021 (v4.2.0.1)
2021 (v4.2.0.0)
2020 (v4.1.0.0)
Perihilar Bile Ducts Current Version
PDF (v4.2.0.0)
Word (v4.2.0.0)
June 2021
Previous Version
2020 (v4.1.0.0)
Small Intestine Current Version
PDF (v4.2.0.0)
Word (v4.2.0.0)
June 2021
Previous Version
2020 (v4.1.0.0)
Stomach Current Version
PDF (v4.2.1.1)
Word (v4.2.1.1)
June 2022
Previous Version
2021
 (v4.2.1.0)
2021 (v4.2.0.0)
2020 (v4.1.0.0)
Gastric HER2 Biomarker Reporting Current Version
PDF (v1.0.0.1)
Word (v1.0.0.1)
June 2017
Previous Version
2014 (v1.0.0.0)

Genitourinary

Kidney, Biopsy Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2020 (v4.0.2.0)
Kidney, Resection Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2020 (v4.0.2.0)
Penis Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2017 (v4.0.1.0)
Prostate Needle Biopsy
Case Level
Current Version
PDF (1.0.0.1)
Word (1.0.0.1)
November 2021
Previous Version
2021 (1.0.0.0)
Prostate Needle Biopsy
Specimen Level
Current Version
PDF
(1.0.0.1)
Word
(1.0.0.1)
November 2021
Previous Version
2021 (1.0.0.0)
Prostate, Resection Current Version
PDF (v4.2.0.1)
Word
 (v4.2.0.1)
November 2021
Previous Version
2021 (v4.2.0.0)
2020(v4.1.0.1)
2019 (v4.0.4.1)
2019 (v4.0.4.0)
Prostate TURP Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2020
(v4.0.5.0)
2019 (v4.0.4.1)
Testis Radical Orchiectomy Current Version
PDF (v4.1.0.1)
Word(v4.1.0.1)
November 2021
Previous Version
2021 (v4.1.0.0)
2019 (v4.0.1.2)
Testis Lymphadenectomy Current Version
PDF (v4.1.0.1)
Word (v4.1.0.1)
November 2021
Previous Version
2021
 (v4.1.0.0)
2019 (v4.0.1.1)
Ureter, Renal Pelvis, Biopsy Current Version
PDF (v2.2.0.0)
Word (v2.2.0.0)
June 2021
Previous Version
2019 (v2.1.0.0)
Ureter, Renal Pelvis, Resection Current Version
PDF (v2.2.0.0)
Word (v2.2.0.0)
June 2021
Previous Version
2019 (v2.1.0.0)
Urethra, Biopsy Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2019 (v4.0.2.0)
Urethra, Resection Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2020
(v4.0.3.0)
2019 (v4.0.2.0)
Urinary Bladder, Resection Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2020
(v4.0.2.0)
2019 (v4.0.1.1)
Urinary Bladder, Biopsy Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2020
(v4.0.2.0)
2019 (v4.0.1.1)

Gynecologic

Endometrium Uterus Current Version
PDF (v4.3.0.0)
Word (v4.3.0.0)
June 2022
Previous Version
2022
 (v4.2.0.2)
2021
 (v4.2.0.1)
2021 (v4.2.0.0)
2020
(v4.1.0.2)
2019 (v4.1.0.1)
Endometrium Biomarker Reporting Current Version
PDF (v1.2.0.1)
Word (v1.2.0.1)
September 2019
Previous Version
2019 (v1.2.0.0)
2016 (v1.1.0.0)
2015 (v1.0.0.0)
Ovary, Fallopian Tube, or Peritoneum Current Version
PDF(v1.3.0.2)
Word (v1.3.0.2)
March 2022
Previous Version
2021 (v1.3.0.1)
2021
 (v1.3.0.0)
2020 (v1.1.1.0)
Trophoblastic Tumors Current Version
PDF (v4.1.0.1)
Word (v4.1.0.1)
November 2021
Previous Version
2021 (v4.1.0.0)
2017 (v4.0.0.0)
Uterine Cervix, Excision Current Version
PDF (v4.4.1.0)
Word (v4.4.1.0)
June 2021
Previous Version
2020
(v4.4.0.0)
2020 (v4.3.0.0)
2019 (v4.2.0.0)
Uterine Cervix, Resection Current Version
PDF (v5.0.1.3)
Word (v5.0.1.3)
March 2022
Previous Version
2021
(v5.0.1.2)
2021 (v5.0.1.1)
2021 (v5.0.1.0)
2020
(v5.0.0.0)
2020 (v4.3.0.0)
Uterine Sarcoma Current Version
PDF (v4.4.0.0)
Word (v4.4.0.0)
March 2022
Previous Version
2021 (v4.3.0.0)
2021
 (v4.2.0.0)
2018 (v4.1.0.0)
Vagina, Biopsy Current Version
PDF (v4.3.0.0)
Word (v4.3.0.0)
June 2021
Previous Version
2019 (v4.2.0.0)
Vagina, Resection Current Version
PDF (v4.3.0.1)
Word(v4.3.0.1)
November 2021
Previous Version
2021 (v4.3.0.0)
2020
(v4.2.0.1)
2019 (v4.2.0.0)
Vulva Current Version
PDF (v4.2.0.2)
Word (v4.2.0.2)
November 2021
Previous Version
2021
 (v4.2.0.1)
2021 (v4.2.0.0)
2020 (v4.1.0.1)

Head and Neck

Larynx Current Version
PDF (v4.1.1.0)
Word (v4.1.1.0)
November 2021
Previous Version
2021
 (v4.1.0.0)
2017 (v4.0.0.1)
Oral Cavity Current Version
PDF (v4.1.1.0)
Word (v4.1.1.0)
November 2021
Previous Version
2021 (v4.1.0.1)
2021 (v4.1.0.0)
2017 (v4.0.0.1)
Major Salivary Glands Current Version
PDF (v4.2.0.0)
Word (v4.2.0.0)
June 2022
Previous Version
2021
 (v4.1.1.0)
2021 (v4.1.0.0)
2017 (v4.0.0.1)
Nasal Cavity and Paranasal Sinuses Current Version
PDF (v4.1.1.0)
Word (v4.1.1.0)
November 2021
Previous Version
2021 (v4.1.0.0)
2017 (v4.0.0.1)
Pharynx Current Version
PDF (v4.1.1.0)
Word (v4.1.1.0)
November 2021
Previous Version
2021
 (v4.1.0.0)
2019 (v4.0.0.2)
Head and Neck Biomarker Reporting Current Version
PDF (v2.0.0.1)
Word (v2.0.0.1)
November 2021
Previous Version
2021 
(v2.0.0.0)
2017
(v1.0.0.0)
Squamous Cell Carcinoma *NEW*Current Version
PDF (v1.0.0.0)
Word (v1.0.0.0)
June 2022

Hematologic

Bone Marrow Current Version
PDF (v4.0.0.0)
Word (v4.0.0.0)
February 2019
Previous Version
2018 (v3.1.0.0)
2017 (v3.0.1.2)
2012 (v3.0.1.1)
Hodgkin Lymphoma Current Version
PDF (v3.1.0.1)
Word (v3.1.0.1)
October 2013
Previous Version
2013 (v3.1.0.0)
Non-Hodgkin Lymphoma Current Version
PDF (v3.2.0.1)
Word (v3.2.0.1)
October 2013
Previous Version
2013 (v3.2.0.0)
Plasma Cell Neoplasms Current Version
PDF (v1.0.0.2)
Word (v1.0.0.2)
January 2015
Previous Version
2015 (v1.0.0.1)
2015 (v1.0.0.0)

Ophthalmic

Retinoblastoma Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2017
(v4.0.0.0)
Uveal Melanoma Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2017
(v4.0.0.0)

Pediatric

Ewing, Resection Current Version
PDF (v4.1.1.0)
Word
(v4.1.1.0)
March 2022
Previous Version
2021 (v4.1.0.0)
2019 (v4.0.0.0)
Ewing, Biopsy Current Version
PDF (v4.1.1.0)
Word (v4.1.1.0)
March 2022
Previous Version
2021 (v4.1.0.0)
2019
(v4.0.0.0)
Germ Cell Tumor, Resection Current Version
PDF (v4.1.1.0)
Word (v4.1.1.0)
March 2022
Previous Version
2021 (v4.1.0.0)
2019
(v4.0.0.0)
Germ Cell Tumor, Biopsy Current Version
PDF (v4.1.1.0)
Word (v4.1.1.0)
March 2022
Previous Version
2021 (v4.1.0.0)
2019
(v4.0.0.0)
Hepatoblastoma, Resection Current Version
PDF (v4.0.2.0)
Word (v4.0.2.0)
March 2022
Previous Version
2021 (v4.0.1.0)
2019 (v4.0.0.0)
Hepatoblastoma, Biopsy Current Version
PDF (v4.0.1.0)
Word (v4.0.1.0)
March 2022
Previous Version
2021 (v4.0.0.1)
2019
(v4.0.0.0)
Neuroblastoma, Resection Current Version
PDF (v4.1.1.0)
Word
(v4.1.1.0)
March 2022
Previous Version
2021 (v4.1.0.0)
2019 (v4.0.0.0)
Neuroblastoma, Biopsy Current Version
PDF (v4.1.1.0)
Word (v4.1.1.0)
March 2022
Previous Version
2021 (v4.1.0.0)
2019
(v4.0.0.0)
Rhabdomyosarcoma, Resection Current Version
PDF (v4.1.1.0)
Word (v4.1.1.0)
March 2022
Previous Version
2021 (v4.1.0.0)
2019 (v4.0.0.0)
Rhabdomyosarcoma, Biopsy Current Version
PDF (v4.1.1.0)
Word (v4.1.1.0)
March 2022
Previous Version
2021 (v4.1.0.0)
2019
(v4.0.0.0)
Wilms, Resection Current Version
PDF (v4.2.0.0)
Word (v4.2.0.0)
March 2022
Previous Version
2021
 (v4.1.0.0)
2019 (v4.0.0.0)
Wilms, Biopsy Current Version
PDF (v4.0.1.0)
Word (v4.0.1.0)
March 2022
Previous Version
2021 (v4.0.0.1)
2019
(v4.0.0.0)

Skin

Skin, Melanoma, Biopsy Current Version
PDF (v4.3.1.0)
Word (v4.3.1.0)
March 2022
Previous Version
2021 (v4.3.0.1)
2021 (v4.3.0.0)
2020 (v4.2.0.0)
2020 (v4.1.1.0)
2019 (v4.1.0.0)
Skin, Melanoma, Excision Current Version
PDF (v4.3.0.2)
Word 
(v4.3.0.2)
November 2021
Previous Version
2021
 (v4.3.0.1)
2021 (v4.3.0.0)
2020
(v4.2.0.0)
2020 (v4.1.0.0)
Melanoma Biomarker Reporting Current Version
PDF (v1.0.0.2)
Word (v1.0.0.2)
July 2015
Previous Version
2015 (v1.0.0.1)
2015 (v1.0.0.0)
Merkel Cell Carcinoma Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2017 (v4.0.0.1)

Thorax

Lung, Resection Current Version
PDF (v4.3.0.0)
Word (v4.3.0.0)
June 2022
Previous Version
2021
 (v4.2.0.1)
2021 (v4.2.0.0)
2020 (v4.1.0.1)
2019 (v4.1.0.0)
Lung Biomarker Reporting Current Version
PDF (v2.0.1.0)
Word (v2.0.1.0)
November 2021
Previous Version
2021 (v2.0.0.0)
2016 (v1.3.0.2) 
Pleural Mesothelioma Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2017 (v4.0.0.1)
Thymus Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2017 (v4.0.0.1)

Bone and Soft Tissue

Bone, Biopsy Current Version
PDF (v4.1.0.1)
Word (v4.1.0.1)
November 2021
Previous Version
2021
(v4.1.0.0)
2020 (v4.0.1.0)
Bone, Resection Current Version
PDF (v4.1.1.0)
Word (v4.1.1.0)
July 2021
Previous Version
2021 
(v4.1.0.0)
2020
(v4.0.1.0)
Soft Tissue, Biopsy Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2020
(v4.0.2.0)
2019 (v4.0.1.1)
Soft Tissue, Resection Current Version
PDF (v4.1.0.0)
Word (v4.1.0.0)
June 2021
Previous Version
2020
(v4.0.2.0)
2019 (v4.0.1.1)

General

DNA Mismatch Repair Biomarker Reporting Current Version
PDF (v1.0.0.2)
Word (v1.0.0.2)
June 2021
Previous Version
2018 (v1.0.0.0)
Generic Template, Biopsy Current Version
PDF (v1.0.1.0)
Word (v1.0.1.0)
June 2021
Previous Version
2019 (v1.0.0.0)
Generic Template, Resection Current Version
PDF (v1.1.0.0)
Word (v1.1.0.0)
June 2021
Previous Version
2019 (v1.0.0.0)
General IHC Quantitative BiomarkersCurrent Version
PDF (1.1.0.0)
Word (1.1.0.0)
November 2021
Previous Version
2021 (1.0.0.0)

CAP Cancer Protocol Usage Limitations and Copyright

© 2022 College of American Pathologists (CAP). All rights reserved.

The College of American Pathologists (CAP) does not permit reproduction of any substantial portion of these protocols without its written authorization. The CAP hereby authorizes use of these protocols by physicians and other health care providers in reporting on surgical specimens, in teaching, and in carrying out medical research for nonprofit purposes. This authorization does not extend to reproduction or other use of any substantial portion of these protocols for commercial purposes without the written consent of the CAP.

The CAP also authorizes physicians and other health care practitioners to make modified versions of the Protocols solely for their individual use in reporting on surgical specimens for individual patients, teaching, and carrying out medical research for non-profit purposes.

The CAP further authorizes the following uses by physicians and other health care practitioners, in reporting on surgical specimens for individual patients, in teaching, and in carrying out medical research for non-profit purposes: (1) Dictation from the original or modified protocols for the purposes of creating a text-based patient record on paper, or in a word processing document; (2) Copying from the original or modified protocols into a text-based patient record on paper, or in a word processing document; (3) The use of a computerized system for items (1) and (2), provided that the protocol data is stored intact as a single text-based document, and is not stored as multiple discrete data fields.

Other than uses (1), (2), and (3) above, the CAP does not authorize any use of the Protocols in electronic medical records systems, pathology informatics systems, cancer registry computer systems, computerized databases, mappings between coding works, or any computerized system without a written license from the CAP.

Any public dissemination of the original or modified protocols is prohibited without a written license from the CAP.

The Protocols include tumor staging data used with permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2020).

The CAP developed these protocols as an educational tool to assist pathologists in the useful reporting of relevant information. It did not issue the protocols for use in litigation, reimbursement, or other contexts. Nevertheless, the CAP recognizes that the protocols might be used by hospitals, attorneys, payers, and others. Indeed, effective January 1, 2004, the Commission on Cancer of the American College of Surgeons mandated the use of the required data elements of the protocols as part of its Cancer Program Standards for Approved Cancer Programs. Therefore, it becomes even more important for pathologists to familiarize themselves with these documents. At the same time, the CAP cautions that use of the protocols other than for their intended educational purpose may involve additional considerations that are beyond the scope of this document.

The inclusion of a product name or service in a CAP publication should not be construed as an endorsement of such product or service, nor is failure to include the name of a product or service to be construed as disapproval.

Back to the top